Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in amyotrophic lateral sclerosis.

A Al-Chalabi1, P N Leigh

  • 1Department of Neurology, Guy's King's and St Thomas' School of Medicine and Institute of Psychiatry, De Crespigny Park, London, UK.

Current Opinion in Neurology
|September 2, 2000
PubMed
Summary

Understanding amyotrophic lateral sclerosis (ALS) mechanisms is crucial. Research explores SOD1 gene mutations, neuroinflammation, and diagnostic tools to improve patient care and survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of cerebrospinal fluid alpha-synuclein seed amplification assay in PSP and CBS.

medRxiv : the preprint server for health sciences·2024
Same author

Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2022
Same author

Depression, anxiety and PTSD symptoms before and during the COVID-19 pandemic in the UK.

Psychological medicine·2022
Same author

Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy.

Journal of the neurological sciences·2021
Same author

Measuring coping in people with amyotrophic lateral sclerosis using the Coping Index-ALS: A patient derived, Rasch compliant scale.

Journal of the neurological sciences·2021
Same author

DNAscan: personal computer compatible NGS analysis, annotation and visualisation.

BMC bioinformatics·2019

Area of Science:

  • Neuroscience
  • Genetics
  • Clinical Neurology

Background:

  • Mechanisms of selective motor neuron death in SOD1-mutated amyotrophic lateral sclerosis (ALS) are unclear.
  • Potential factors include peroxynitrite, altered SOD1 peroxidase activity, copper homeostasis disruption, protein aggregation, and excitotoxicity via glutamate transporters.
  • Neurofilaments, peripherin, and neurofilament heavy chain gene mutations are implicated in motor neuron degeneration.

Purpose of the Study:

  • To review current understanding of ALS pathogenesis, focusing on SOD1 mutations.
  • To discuss diagnostic advancements and clinical aspects of ALS.
  • To evaluate current management strategies and quality of life measures in ALS care.

Main Methods:

  • Review of existing literature on SOD1 gene mutations and ALS.

Related Experiment Videos

  • Analysis of clinical studies on ALS incidence, prevalence, and variants.
  • Evaluation of neuroimaging and electrophysiological techniques for diagnosing upper motor neuron lesions.
  • Assessment of current care practices, including ventilation, nutrition, and patient autonomy.

    • Main Results:

    • While specific mechanisms remain elusive, several pathways are investigated for SOD1-related ALS.
    • Genetic linkage studies have identified loci but not new genes for familial ALS.
    • Diagnostic tools like transcranial magnetic stimulation and MRI provide insights into upper motor neuron damage.
    • Riluzole, non-invasive ventilation, and gastrostomy are key interventions for extending survival.

    Conclusions:

    • Further research is needed to elucidate the precise mechanisms of SOD1-mediated motor neuron death in ALS.
    • Improved diagnostic methods and understanding of clinical variants aid in patient management.
    • Multifaceted care approaches, including pharmacological and supportive interventions, are essential for improving quality of life and survival in ALS patients.